Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (year values)

2021 2022 2023 2024 2025   LTM ?
EV/EBITDA ? -15.2 -18.5 -47.2 104.2 85.1   66.4
Changes by years, y/y, % -38% +21% +155% -321% -18%    

Amicus Therapeutics. EV/EBITDA

Amicus Therapeutics. EV/EBITDA, changes, %

Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (quarter values)

2024Q4 2025Q1 2025Q2 2025Q3 2025Q4   LTM ?
EV/EBITDA ? 102.4 50.4 59.8 44.0 85.3   66.4
Changes by years, y/y, % -318% -208% -175% -112% -17%    
Changes by quarters, q/q, % -127% -51% +19% -26% +94%    

Amicus Therapeutics. EV/EBITDA

Amicus Therapeutics. EV/EBITDA, changes, y/y, %

Amicus Therapeutics. EV/EBITDA, changes, q/q, %